Concanavalin A-activated suppressor cell activity in gastric cancer patients. 1980

T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori

Peripheral blood lymphocytes from both normal donors and gastric cancer patients contained suppressor cells which could be activated by concanavalin A (Con A) to suppress the proliferative response of lymphocytes from a normal donor. Con A-activated suppressor cells resided in the E rosette-forming cell fraction. An apparent inverse relationship was found between Con A-activated suppressor cell activity and lymphocyte proliferative response to phytohemagglutinin. Significant increases of suppressor cell activities were found in advanced gastric cancer patients. These activities decreased remarkably after surgical resection of the primary tumors. It is likely that nonspecific suppressor cells represent one of the major factors inducing immunosuppression in gastric cancer patients.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell

Related Publications

T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
September 1980, Journal of the National Cancer Institute,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
July 1986, The Indian journal of medical research,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
January 1982, The Journal of rheumatology,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
January 1979, Scandinavian journal of immunology,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
July 1985, Zhonghua nei ke za zhi,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
December 1991, Cancer,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
May 1982, Transplantation,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
February 1984, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
January 1982, Journal of cancer research and clinical oncology,
T Toge, and E Yanagawa, and K Nakanishi, and Y Yamada, and M Niimoto, and T Hattori
August 1980, Clinical immunology and immunopathology,
Copied contents to your clipboard!